Pain by Etiology

  • Maurice E. Hamilton
Part of the Current Clinical Practice book series (CCP)

Keywords

Morphine Prednisone Clonidine Appendicitis Paroxetine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arvin AM. Aspects of the host response to varicella-zoster virus: a review of recent observations. Neurology 1995; 45: S36–37.PubMedCrossRefGoogle Scholar
  2. 2.
    Rowbotham M. From mechanisms to clinical syndromes: a comparison of post-herpetic neuralgia and complex regional pain syndromes (RSD and causalgia). Pain symposium. American Academy of Neurology 48th Annual Meeting, San Francisco, March 24, 1996: 1-36.Google Scholar
  3. 3.
    Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45: S41–46.PubMedCrossRefGoogle Scholar
  4. 4.
    Pavan-Langston D. Herpes zoster ophthalmicus. Neurology 1995; 45: S50–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Eng J Med 1996; 335: 32–42.CrossRefGoogle Scholar
  6. 6.
    Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995; 45:S56–57.PubMedCrossRefGoogle Scholar
  7. 7.
    Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann Int Med 1995; 123: 89–96.PubMedGoogle Scholar
  8. 8.
    Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546–1553.PubMedCrossRefGoogle Scholar
  9. 9.
    Valacyclovir. Med Lett Drugs Ther 1996; 38: 3,4.Google Scholar
  10. 10.
    Whitley RJ. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology 1995; 45: S73–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Tyring SK. Early treatment of herpes zoster. Hospital Practice 1996; 31: 137–144.PubMedGoogle Scholar
  12. 12.
    Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandai BK, Crooks J. A randomized trial of acyclovir for 7 days of 21 days with and without prednisolone for treatment of acute herpes zoster. N Eng J Med 1994; 330: 896–900.CrossRefGoogle Scholar
  13. 13.
    Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Int Med 1996; 125: 376–383.PubMedGoogle Scholar
  14. 14.
    Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643–647.PubMedCrossRefGoogle Scholar
  15. 15.
    Varicella vaccine. Med Lett Drugs Ther 1995; 37: 55–57.Google Scholar
  16. 16.
    American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995; 95: 791–796.Google Scholar
  17. 17.
    Merskey H, Bogduk N, eds. Classification of chronic pain. 2nd ed. Seattle: IASP, 1994.Google Scholar
  18. 18.
    Bruxelle J. Prospective epidemiologic study of painful and neurologic sequelae induced by herpes zoster in patients treated early with oral acyclovir. Neurology 1995; 45: S78,79.PubMedCrossRefGoogle Scholar
  19. 19.
    Johnson RW. The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 1995; 45:S70–72.PubMedCrossRefGoogle Scholar
  20. 20.
    Rowbotham MC. Managing post-herpetic neuralgia with opioids and local anesthetics. Ann Neurol 1994; 35:S46–49.PubMedCrossRefGoogle Scholar
  21. 21.
    Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989; 39: 129–144.PubMedCrossRefGoogle Scholar
  22. 22.
    Watson CPN. The treatment of postherpetic neuralgia. Neurology 1995; 45: S58–S60.PubMedCrossRefGoogle Scholar
  23. 23.
    Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994; 35: S50–53.PubMedCrossRefGoogle Scholar
  24. 24.
    Watson CPN, Tyler KL, Bickers DR. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510–526.PubMedGoogle Scholar
  25. 25.
    Boon RJ, Griffin DRJ. Efficacy of famciclovir in the treatment of herpes zoster. Neurology 1995; 45: S76,77.PubMedCrossRefGoogle Scholar
  26. 26.
    Gonzales GR. Central pain. Sem Neurol 1994; 14: 255–262.CrossRefGoogle Scholar
  27. 27.
    Portenoy RK. Neuropathic pain. In: Portenoy RK, Kanner RM, eds. Pain Management: Theory and Practice. Philadelphia: F. A. Davis, 1996; 83–125.Google Scholar
  28. 28.
    Boivie J, Leijon G. Clinical findings in patients with central poststroke pain. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 65–75.Google Scholar
  29. 29.
    Casey KL. Pain and central nervous system disease: a summary and overview. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 1–11.Google Scholar
  30. 30.
    Gonzales GR. Central pain: diagnosis and treatment strategies. Neurology 1995; 45: S11–16.PubMedCrossRefGoogle Scholar
  31. 31.
    Beric A. Central pain: “new” syndromes and their evaluation. Muscle & Nerve 1993; 16: 1017–1024.CrossRefGoogle Scholar
  32. 32.
    Boivie J, Leijon G. Pharmacologic treatment of central pain. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 257–266.Google Scholar
  33. 33.
    Herman RM, D’Luzansky SC, Ippolito R. Intrathecal Baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992; 8: 338–345.CrossRefGoogle Scholar
  34. 34.
    Leijon G, Boivie J. Central post-stroke pain—the effect of high and low frequency TENS. Pain 1989; 38: 187–191.PubMedCrossRefGoogle Scholar
  35. 35.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, D.C.: American Psychiatric Association, 1994.Google Scholar
  36. 36.
    King SA. Review: DSM-IV and pain. Clin J Pain 1995; 11: 171–176.PubMedCrossRefGoogle Scholar
  37. 37.
    Lim LEC. Psychogenic pain. Singapore Med J 1994; 35: 519–522.PubMedGoogle Scholar
  38. 38.
    Pilowsky I, Barrow G. Predictors of outcome in the treatment of chronic “psychogenic” pain with amitriptyline and brief psychotherapy. Clin J Pain 1992; 8: 358–362.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Maurice E. Hamilton

There are no affiliations available

Personalised recommendations